Cervical Cancer Facts & Resources

An overview of cervical cancer

Cervical cancer is a type of cancer that starts in the cervix. The cervix is the lowest portion of the uterus which connects the uterus to the vagina. When screening for cervical cancer, cells are collected from this area and tested for high-risk HPV (human papillomavirus), as nearly all cervical cancer is caused by HPV.

Once one of the most common causes of cancer death in American women, the incidence of cervical cancer declined significantly thanks to early screening.1 However, over the past decade, screening has been on the decline and cervical cancer rates are rising, particularly among 30-44 years.

According to the American Cancer Society, cervical cancer rarely occurs in people who have been getting regular tests to screen for cervical cancer.1 Screening saves lives, yet preventable diagnoses and deaths are still happening. Lack of awareness and education, shame, fear, and access to quality healthcare with a trusted provider are just a few of the many reasons women avoid routine screening.

Additionally, the method for screening has remained the same over the years. The inconveniences of going to a doctor’s office for a cervical cancer screening test include, but are certainly not limited to: time, geography, and the perceived and actual discomfort of screening exams.

We cannot let these factors continue to impede all of the progress that’s been made in women’s health—especially for a disease that is so preventable.

Women deserve better.
Teal is on a mission to get all women screened for cervical cancer.

Current state of cervical cancer in the United States:
Facts & Figures3

Cervical cancer is nearly 100% preventable, yet

13,820

cases of invasive cervical cancer will be diagnosed in 2024.

4,360

women will die from cervical cancer in 2024.

50%+

of cervical cancer cases are among women who are not up-to-date on their screening.

30-44 years old

Cervical cancer incidence in the US is increasing in women 30-44 years old.

3rd most common

Cervical cancer has moved up to become the third most common cancer death among young women after an uptick since 2019.

How traditional in-clinic screening works:

The breakdown:

SCHEDULE AN APPOINTMENT

Traditionally, cervical cancer screening is performed in-person, usually during your annual exam with your primary care provider or at your annual well-woman appointment with your OBGYN. 


COLLECT CELLS

To screen for high-risk HPV, the clinician collects the cells (using a speculum & cervical brush). The clinician then inserts the brush into a preservation solution. See below for the future of screening.

TESTED AT LAB

The solution is then sent to the lab with an order from the physician to perform either the HPV test and/or Pap smear on the sample. Visit our Primary HPV page to learn about the difference between HPV testing and Pap testing.

GET RESULTS

Results are reported to the patient within 1-3 weeks. If results are Abnormal (either positive HPV or abnormal Pap), speak to a doctor about follow up steps.

INSURANCE

Cervical cancer screening is a Grade A preventive screening. All insurance covers the cervical cancer screening test according to the guidelines (3-5 yrs or more frequent if recommended by a provider).

The traditional in-clinic screening process is resulting in health inequities that need to be addressed:

Asian Women are

Least likely to get screened, with over a third never being screened or being overdue.8

hispanic women are

40% more likely to be diagnosed with cervical cancer than white women.9

black & native american women have

a cervical cancer death rate that is 65% higher than white women.3

The future of at-home cervical cancer screening

Teal Health’s focus is on getting all women screened for cervical cancer, with a comfortable, accurate self-collect option that can be done from the convenience of home. The opportunities for improved access and early cancer detection through widespread, at-home self-collection are very promising. Visit our Teal Wand page to learn how at-home screening works.

Today, 1 in 4 women in the US are not up-to-date on their cervical cancer screening. In Teal’s SELF-CERV clinical study, 86% of the women who participated said that if at-home self-collection were available, they would get screened on time, every time. Additionally, 94% of participants said they preferred self-collection compared to having a clinician collect a sample with a speculum and a brush.10 Learn more about Teal's SELF-CERV clinical study, which led to the Teal WandTM becoming the first at-home self-collection device for cervical cancer screening to be FDA-approved. See how it compares to the traditional in-clinic when FDA approved, and how it compares to the traditional in-clinic screening method and join the waitlist to be alerted when it is available in your state.

Here are some of the ways we predict at-home self-collect cervical cancer screening will have a positive impact on women’s healthcare:

Join us in creating an equitable and accessible women's healthcare system - starting with cervical cancer screenings.

Your experience matters

Signup to be the first to know when we’re available in your state.

Thank you!
Your submission has been received!
Oops! Something went wrong while submitting the form.
LBL-012 Rev 1.1